Search by Drug Name or NDC
NDC 29300-0169-19 Tizanidine 4 mg/1 Details
Tizanidine 4 mg/1
Tizanidine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Unichem Pharmaceuticals (USA), Inc.. The primary component is TIZANIDINE HYDROCHLORIDE.
Product Information
| NDC | 29300-0169 |
|---|---|
| Product ID | 29300-169_1ff0cf9a-9b0b-4733-9ed7-315a09c60555 |
| Associated GPIs | 75100090100320 |
| GCN Sequence Number | 030274 |
| GCN Sequence Number Description | tizanidine HCl TABLET 4 MG ORAL |
| HIC3 | H6H |
| HIC3 Description | SKELETAL MUSCLE RELAXANTS |
| GCN | 14693 |
| HICL Sequence Number | 011582 |
| HICL Sequence Number Description | TIZANIDINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Tizanidine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tizanidine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | mg/1 |
| Substance Name | TIZANIDINE HYDROCHLORIDE |
| Labeler Name | Unichem Pharmaceuticals (USA), Inc. |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA091283 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 29300-0169-19 (29300016919)
| NDC Package Code | 29300-169-19 |
|---|---|
| Billing NDC | 29300016919 |
| Package | 90 TABLET in 1 BOTTLE, PLASTIC (29300-169-19) |
| Marketing Start Date | 2023-01-06 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |